Andrew Lockhart

Senior Vice President, Head Translational Disease Understanding @Grünenthal Group

Aachen, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2020 — Present

Senior Vice President, Head Translational Disease Understanding @Grünenthal Group

View department →

Aachen, DE

EDUCATION

1998 — 2001

Birkbeck, University of London

PhD, Protein Chemistry

1984 — 1988

University of Surrey

BSc, Biochemistry

SKILLS

BiochemistryDrug DiscoveryAssay DevelopmentProtein ChemistryBiotechnologyResearch and Development (R&D)Digital ImagingLifesciencesPharmaceutical IndustryTranslational MedicineBiomarkersLife SciencesIn VitroBiomarker DiscoveryMedical ResearchTranslational ResearchNeurodegenerationR&DNeurodegenerative DiseasesClinical TrialsNeurologyMolecular BiologyCROPharmacologyClinical ResearchImagingClinical DevelopmentNeuroscienceAlzheimer's DiseaseDrug DevelopmentBiopharmaceuticals

ABOUT ANDREW LOCKHART

Experienced drug developer with significant (>20 years) preclinical, translational and clinical leadership experience in both large pharma and biotech environments> Substantial leadership expertise in the development and implementation of integrated translational/ experimental medicine strategies in support of early clinical development> Portfolio-level management experience of drug development projects> Specialist scientific and translation knowledge across Neurosciences > Demonstrated experience in blending global (US-European-Asian), cross-functional expertise into effective, goal orientated and empowered teams

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.